NCT01798004 2024-07-15
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Children's Oncology Group
Phase 1 Completed
Children's Oncology Group
Eli Lilly and Company
Baylor College of Medicine
University of Pittsburgh
City of Hope Medical Center
Children's Oncology Group
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital